Guggenheim Capital’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PCM
AA
Guggenheim Capital's OGN Position: Q2 2026 in Review
Guggenheim Capital reduced its Organon & Co (OGN) stake by 35% in Q2 2026, selling an estimated $363K and leaving 56,481 shares worth $765K. The position accounts for ﹤0.01% of the portfolio, ranked #1119.
Guggenheim Capital first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $3.87M in Q1 2022. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- Guggenheim Capital held 56,481 shares of Organon & Co worth $765K as of Q2 2026.
- Guggenheim Capital sold 30,341 Organon & Co shares in Q2 2026, an estimated $363K.
- Organon & Co made up ﹤0.01% of Guggenheim Capital's portfolio in Q2 2026, its #1119 holding.
- Guggenheim Capital first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
- Guggenheim Capital's Organon & Co position peaked at $3.87M in Q1 2022.
- 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.